QA procedures for multimodality preclinical tumor drug response testing.

about

Construction of a preclinical multimodality phantom using tissue-mimicking materials for quality assurance in tumor size measurement.

P2860

Q41828265-6E3A3184-DA15-4405-8E3D-F82AA92F2618

P2860

QA procedures for multimodality preclinical tumor drug response testing.

Item

http://www.wikidata.org/entity/Q53264976

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

QA procedures for multimodality preclinical tumor drug response testing.

@en

QA procedures for multimodality preclinical tumor drug response testing.

@nl

type

Item

label

QA procedures for multimodality preclinical tumor drug response testing.

@en

QA procedures for multimodality preclinical tumor drug response testing.

@nl

prefLabel

QA procedures for multimodality preclinical tumor drug response testing.

@en

QA procedures for multimodality preclinical tumor drug response testing.

@nl

P1476

QA procedures for multimodality preclinical tumor drug response testing.

@en

P2093

Beth A Goins

http://www.w3.org/2001/XMLSchema#string

Gary D Fullerton

http://www.w3.org/2001/XMLSchema#string

Yongsook C Lee

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Tissue mimicking materials for a multi-imaging modality prostate phantom.

Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper.

Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer.

RECIST revisited: a review of validation studies on tumour assessment.

Dedicated small animal scanners: a new tool for drug development?

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Small animal PET.

Small animal SPECT and its place in the matrix of molecular imaging technologies.

P304

4806-4816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1118/1.3464491

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20964200

http://www.w3.org/2001/XMLSchema#string

QA procedures for multimodality preclinical tumor drug response testing.

about

P2860

P2860

QA procedures for multimodality preclinical tumor drug response testing.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698